StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)

StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report sent to investors on Friday. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Down 3.1 %

Shares of Enzo Biochem stock opened at $0.46 on Friday. Enzo Biochem has a 12-month low of $0.41 and a 12-month high of $1.32. The company has a 50-day moving average of $0.60 and a two-hundred day moving average of $0.90.

Enzo Biochem (NYSE:ENZ) last issued its quarterly earnings data on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Trading of Enzo Biochem

Hedge funds and other institutional investors have recently bought and sold shares of the company. Virtu Financial LLC purchased a new stake in Enzo Biochem in the 4th quarter worth approximately $35,000. Lepercq Multi Asset Fund purchased a new stake in Enzo Biochem in the 4th quarter worth approximately $88,000. BBR Partners LLC purchased a new stake in Enzo Biochem in the 3rd quarter worth approximately $112,000. Wittenberg Investment Management Inc. grew its stake in Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after acquiring an additional 70,400 shares during the period. Finally, Geode Capital Management LLC grew its stake in Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares during the period. 36.90% of the stock is owned by hedge funds and other institutional investors.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.